These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 17381378)
1. Clinical utility of a continuous intravenous infusion of valproic acid in pediatric patients. Taylor LM; Farzam F; Cook AM; Lewis DA; Baumann RJ; Kuhn RJ Pharmacotherapy; 2007 Apr; 27(4):519-25. PubMed ID: 17381378 [TBL] [Abstract][Full Text] [Related]
2. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate. Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion. Cook AM; Zafar MS; Mathias S; Stewart AM; Albuja AC; Bensalem-Owen M; Kapoor S; Baumann RJ CNS Drugs; 2016 Jan; 30(1):71-7. PubMed ID: 26715390 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for hyperammonemia in pediatric patients with epilepsy. Yamamoto Y; Takahashi Y; Imai K; Mishima N; Yazawa R; Inoue K; Itoh K; Kagawa Y; Inoue Y Epilepsia; 2013 Jun; 54(6):983-9. PubMed ID: 23409971 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine. Reiter PD; Nickisch J; Merritt G Headache; 2005; 45(7):899-903. PubMed ID: 15985107 [TBL] [Abstract][Full Text] [Related]
6. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit. Boggs JG; Preis K Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337 [TBL] [Abstract][Full Text] [Related]
7. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Hovinga CA; Chicella MF; Rose DF; Eades SK; Dalton JT; Phelps SJ Ann Pharmacother; 1999 May; 33(5):579-84. PubMed ID: 10369622 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977 [TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients. Van Matre ET; Cook AM Neurol Res; 2016 Sep; 38(9):786-91. PubMed ID: 27414414 [TBL] [Abstract][Full Text] [Related]
11. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children. Wolf GK; McClain CD; Zurakowski D; Dodson B; McManus ML Pediatr Crit Care Med; 2006 Sep; 7(5):434-9; quiz 440. PubMed ID: 16885794 [TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication. May TW; Boor R; Rambeck B; Jürgens U; Korn-Merker E; Brandt C Ther Drug Monit; 2011 Apr; 33(2):214-21. PubMed ID: 21383651 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children. Visudtibhan A; Bhudhisawadi K; Vaewpanich J; Chulavatnatol S; Kaojareon S Brain Dev; 2011 Mar; 33(3):189-94. PubMed ID: 20444563 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Yu KT; Mills S; Thompson N; Cunanan C Epilepsia; 2003 May; 44(5):724-6. PubMed ID: 12752474 [TBL] [Abstract][Full Text] [Related]
15. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068 [TBL] [Abstract][Full Text] [Related]
16. Continuous Intravenous Valproate as Abortive Therapy for Pediatric Status Migrainosus. Zafar MS; Stewart AM; Toupin DN; Cook AM; Baumann RJ Neurologist; 2018 Mar; 23(2):43-46. PubMed ID: 29494433 [TBL] [Abstract][Full Text] [Related]
17. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants. Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children. Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762 [TBL] [Abstract][Full Text] [Related]
19. Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children. Ueshima S; Aiba T; Makita T; Nishihara S; Kitamura Y; Kurosaki Y; Kawasaki H; Sendo T; Ohtsuka Y; Gomita Y J Clin Pharm Ther; 2008 Feb; 33(1):31-8. PubMed ID: 18211614 [TBL] [Abstract][Full Text] [Related]